These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 38414830)
1. Evaluating drug stability and sterility in single-dose vials when accessed with a closed system transfer device. Hopkins JN; Waldman M; Sahai R; Battle J SAGE Open Med; 2024; 12():20503121241230449. PubMed ID: 38414830 [TBL] [Abstract][Full Text] [Related]
2. Evaluating Sterility of Single Dose Vials on an Automated Compounding Device. Hutchinson HM; Sayre BE; Prettyman T; King E Hosp Pharm; 2017 Apr; 52(4):286-293. PubMed ID: 28515508 [No Abstract] [Full Text] [Related]
3. Review of studies examining microbial contamination of vials used for preparations done with closed-system drug transfer devices. Soubieux A; Tanguay C; Bussières JF Eur J Hosp Pharm; 2021 Mar; 28(2):65-70. PubMed ID: 33608432 [TBL] [Abstract][Full Text] [Related]
4. Cost savings realized by use of the PhaSeal(®) closed-system transfer device for preparation of antineoplastic agents. Edwards MS; Solimando DA; Grollman FR; Pang JL; Chasick AH; Hightman CM; Johnson AD; Mickens MG; Preston LM J Oncol Pharm Pract; 2013 Dec; 19(4):338-47. PubMed ID: 23975556 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding. Soefje S; Rickabaugh K; Rajkumar R; Wall KP Int J Pharm Compd; 2021; 25(6):515-522. PubMed ID: 34807847 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding. Soefje S; Rickabaugh K; Rajkumar R; Wall KP Int J Pharm Compd; 2022; 26(1):72-79. PubMed ID: 35081047 [TBL] [Abstract][Full Text] [Related]
7. Multiple withdrawals from single-use vials: a study on sterility. Ripoll Gallardo A; Meneghetti G; Ragazzoni L; Kroumova V; Ferrante D; Ingrassia PL; Ruzza P; Dell'Era A; Boniolo E; Koraqe G; Faggiano F; Della Corte F Int J Pharm; 2015 May; 485(1-2):160-3. PubMed ID: 25769293 [TBL] [Abstract][Full Text] [Related]
8. 28 Validation of a closed system for dispensing serum eye drops. Hogg P; Vere R; Elen D; Lomas R; Chandrasekar A; Rooney P BMJ Open Ophthalmol; 2022 Nov; 7(Suppl 2):A12. PubMed ID: 37282689 [TBL] [Abstract][Full Text] [Related]
9. Stability of Opened Durvalumab (IMFINZI) Vials. The Beginning of the End of Costly Product Wastage? Porlier A; Gagnon PY; Chénard V; Veillette M; Bertrand N; Duchaine C; Michael NJ; Simard C; Drolet B J Pharm Sci; 2023 Sep; 112(9):2412-2418. PubMed ID: 37390868 [TBL] [Abstract][Full Text] [Related]
10. Economic and microbiologic evaluation of single-dose vial extension for hazardous drugs. Rowe EC; Savage SW; Rutala WA; Weber DJ; Gergen-Teague M; Eckel SF J Oncol Pract; 2012 Jul; 8(4):e45-9. PubMed ID: 23180998 [TBL] [Abstract][Full Text] [Related]
11. Thermal stability and storage of human insulin. Richter B; Bongaerts B; Metzendorf MI Cochrane Database Syst Rev; 2023 Nov; 11(11):CD015385. PubMed ID: 37930742 [TBL] [Abstract][Full Text] [Related]
12. Estimation of the wastage rate of MMR and pentavalent vaccines in open and closed vials in three western provinces of Iran. Zahraei SM; Zamani G; Mohammadbeigi A; Asgarian A; Afrashteh S; Gharibnavaz H; Haghgou M; Kone S Heliyon; 2020 May; 6(5):e04016. PubMed ID: 32462097 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the sterility, stability, and efficacy of bevacizumab stored in multiple-dose vials for 6 months. Chen YH; Wu PC; Shiea J; Lo LH; Wu YC; Kuo HK J Ocul Pharmacol Ther; 2009 Feb; 25(1):65-9. PubMed ID: 19232008 [TBL] [Abstract][Full Text] [Related]
14. Microbial contamination of single- and multiple-dose vials after opening in a pulmonary teaching hospital. Baniasadi S; Dorudinia A; Mobarhan M; Karimi Gamishan M; Fahimi F Braz J Infect Dis; 2013; 17(1):69-73. PubMed ID: 23294643 [TBL] [Abstract][Full Text] [Related]
15. Extending Practical (In Use) Shelf Life of Oncology Drug Vials Using Spikes. Wilde S; Crul M; Breukels O Int J Pharm Compd; 2023; 27(2):154-159. PubMed ID: 37000139 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Physico-Chemical and Biological Stability of SB8 (Aybintio), a Proposed Biosimilar to Bevacizumab, Under Ambient and In-Use Conditions. Park D; Kim J; Yun J; Park SJ Adv Ther; 2020 Oct; 37(10):4308-4324. PubMed ID: 32816233 [TBL] [Abstract][Full Text] [Related]
17. Stability of 10 mg/mL cefuroxime solution for intracameral injection in commonly used polypropylene syringes and new ready-to-use cyclic olefin copolymer sterile vials using the LC-UV stability-indicating method. Feutry F; Simon N; Genay S; Lannoy D; Barthélémy C; Décaudin B; Labalette P; Odou P Drug Dev Ind Pharm; 2016 Jan; 42(1):166-174. PubMed ID: 26006333 [TBL] [Abstract][Full Text] [Related]
18. Anticancer drug waste minimization and cost-saving study by using a closed-system transfer device for chemotherapy compounding. Adade CA; Diop BB; Attjioui H; Cheikh A; Mefetah H; Bouatia M J Oncol Pharm Pract; 2022 Apr; 28(3):605-612. PubMed ID: 33847197 [TBL] [Abstract][Full Text] [Related]